Regulation of insulin degrading enzyme activity by obesity-associated factors and pioglitazone in liver of diet-induced obese mice.
Insulin degrading enzyme (IDE) is a potential drug target in the treatment of type 2 diabetes (T2D). IDE controls circulating insulin through a degradation-dependent clearance mechanism in multiple tissues. However, there is not sufficient information about IDE regulation in obesity. In this study,...
Main Authors: | Xiuqing Wei, Bilun Ke, Zhiyun Zhao, Xin Ye, Zhanguo Gao, Jianping Ye |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3989328?pdf=render |
Similar Items
-
Pioglitazone increases whole body insulin sensitivity in obese, insulin-resistant rhesus monkeys.
by: Effie Tozzo, et al.
Published: (2015-01-01) -
Effects and Potential Mechanisms of Pioglitazone on Lipid Metabolism in Obese Diabetic KKAy Mice
by: Jun Peng, et al.
Published: (2014-01-01) -
Leptolide Improves Insulin Resistance in Diet-Induced Obese Mice
by: Pablo Villa-Pérez, et al.
Published: (2017-09-01) -
Restoration of mRNA Expression of Solute Carrier Proteins in Liver of Diet-Induced Obese Mice by Metformin
by: Jiamei Le, et al.
Published: (2021-09-01) -
Effects of pioglitazone mediated activation of PPAR-γ on CIDEC and obesity related changes in mice.
by: Bilal Haider Shamsi, et al.
Published: (2014-01-01)